Ibritumomab Tiuxetan and Paclitaxel (Conventional)
Determining the interaction of Ibritumomab Tiuxetan and Paclitaxel (Conventional) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Paclitaxel Concentrate Injection
- Ibritumomab Tiuxetan-Paclitaxel Intravenous
- Ibritumomab Tiuxetan-Paclitaxel Novaplus
- Ibritumomab Tiuxetan-Paclitaxel protein-bound
- Ibritumomab Tiuxetan-Paclitaxel protein-bound Intravenous
- Ibritumomab Tiuxetan-Pacnex
- Paclitaxel (Conventional)-Ibrutinib
- Paclitaxel (Conventional)-Ibrutinib Capsules
- Paclitaxel (Conventional)-Ibrutinib Tablets
- Paclitaxel (Conventional)-Ibu
- Paclitaxel (Conventional)-IBU Tablets
- Paclitaxel (Conventional)-Ibu-2